Limitless X Holdings Files Q3 2024 10-Q

Ticker: LIMX · Form: 10-Q · Filed: Dec 23, 2024 · CIK: 1803977

Sentiment: neutral

Topics: 10-Q, quarterly-report, amusement-recreation

TL;DR

Limitless X Holdings Q3 10-Q is in. Check financials for the amusement & rec biz.

AI Summary

Limitless X Holdings Inc. filed its Q3 10-Q report for the period ending September 30, 2024. The company, formerly known as BIO LAB NATURALS, INC., is incorporated in Delaware and operates in the amusement and recreation sector. Its principal business address is in Beverly Hills, California.

Why It Matters

This filing provides investors with the latest financial performance and operational updates for Limitless X Holdings Inc. during the third quarter of 2024.

Risk Assessment

Risk Level: low — The filing is a standard quarterly report with no immediate red flags or significant negative disclosures.

Key Players & Entities

FAQ

What is the primary business of Limitless X Holdings Inc.?

Limitless X Holdings Inc. operates in the SERVICES-MISCELLANEOUS AMUSEMENT & RECREATION sector, with SIC code 7990.

When was Limitless X Holdings Inc. formerly known as?

The company was formerly known as BIO LAB NATURALS, INC., with a name change date of February 19, 2020.

What is the fiscal year end for Limitless X Holdings Inc.?

The fiscal year end for Limitless X Holdings Inc. is December 31st.

What is the SEC file number for Limitless X Holdings Inc.?

The SEC file number for Limitless X Holdings Inc. is 000-56453.

Where is the principal business address of Limitless X Holdings Inc.?

The principal business address is 9454 WILSHIRE BLVD., #300, BEVERLY HILLS, CA 90212.

Filing Stats: 4,538 words · 18 min read · ~15 pages · Grade level 15.2 · Accepted 2024-12-23 17:22:40

Filing Documents

Financial Statements

Financial Statements 1 Unaudited Condensed Consolidated Balance Sheets 1 Unaudited Condensed Consolidated Statements of Operations 2 Unaudited Condensed Consolidated Statement of Changes in Stockholders' Deficit 3 Unaudited Condensed Consolidated Statements of Cash Flows 4 Notes to the Unaudited Condensed Consolidated Financial Statements 5 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 22 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 27 Item 4.

Controls and Procedures

Controls and Procedures 27

– OTHER INFORMATION

PART II – OTHER INFORMATION Item 1.

Legal Proceedings

Legal Proceedings 28 Item 1A.

Risk Factors

Risk Factors 28 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 28 Item 3. Defaults Upon Senior Securities 28 Item 4. Mine Safety Disclosures 28 Item 5. Other Information 28 Item 6. Exhibits 28

Signatures

Signatures 29 i LIMITLESS X HOLDINGS INC. PART I – FINANCIAL INFORMATION Item 1. Financial Statements LIMITLESS X HOLDINGS INC. CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) September 30, December 31, 2024 2023 ASSETS Current Assets: Cash $ 24,301 $ 116,100 Accounts receivables, net 24,984 116,888 Inventories 28,434 21,857 Prepaid expenses - 12,500 Total current assets 77,719 267,345 Non-Current Assets: Property and equipment, net 27,096 29,410 Other assets 10,985 10,985 Total non-current assets 38,081 40,395 Total assets $ 115,800 $ 307,740 LIABILITIES AND STOCKHOLDERS' DEFICIT Current Liabilities: Accounts payable and accrued expenses $ 5,151,724 7,318,230 Accrued interest 944,091 531,148 Royalty payable 154,180 - Refunds and chargeback payable 29,320 62,264 Note payable 35,000 35,000 Notes payable to shareholder 5,144,460 5,152,028 Notes payable to related parties 433,544 80,000 Notes payable 433,544 80,000 Loan payable 343,934 - Total current liabilities 12,236,253 13,178,670 Total liabilities 12,236,253 13,178,670 Commitments and contingencies - Preferred Stock B - $ 0.0001 par value; 30,000,000 authorized shares; 531,356 and 10,349,097 shares issued and outstanding, respectively 1,742,953 16,973,554 Stockholders' deficit Preferred Stock A - $ 0.0001 par value; 30,000,000 authorized shares; 500,000 shares issued and outstanding 50 50 Common Stock- $ 0.0001 par value; 300,000,000 authorized shares; 7,179,961 shares and 3,977,497 shares issued and outstanding, respectively 719 399 Common stock issuable 15,230,601 - Additional paid-in-capital 7,995,212 4,793,068 Retained earnings ( 37,089,988 ) ( 34,638,001 ) Total stockholders' deficit ( 13,863,406 ) ( 29,844,484 ) Total liabilities and stockholders' deficit $ 115,800 $ 307,740 The accompanying notes are an integral part of these unaudited condensed consolidat

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing